Septerna (SEPN) EBIT Margin (2023 - 2026)

Septerna's (SEPN) quarterly EBIT Margin came in at 50.19% in Q1 2026, up 1178086.0% year-on-year from N/an in Q1 2025, and up 24.46% quarter-over-quarter from 66.44% in Q4 2025.

Septerna (SEPN) EBIT Margin (2023 - 2026) Analysis & Trends

Septerna's EBIT Margin history runs 4 years deep, the most recent figure standing at 50.19% for Q1 2026.

  • On a quarterly basis, EBIT Margin rose 1178086.0% year-over-year to 50.19% in Q1 2026; TTM through Mar 2026 was 77.09%, a 926200.0% increase from a year earlier, with the FY2025 full-year figure at 148.63%, up 736979.0% from the prior year.
  • EBIT Margin advanced to 50.19% in Q1 2026 per SEPN's latest filing, from 66.44% in the prior quarter.
  • Across five years, EBIT Margin topped out at 29082.2% in Q4 2023 and bottomed at 36484.85% in Q3 2023.
  • The 4-year median for EBIT Margin is 4886.44% (2024), against an average of 7084.57%.
  • Biggest YoY gain for EBIT Margin was 2367235 bps in 2024; the steepest drop was 4074164 bps in 2024.
  • Year by year, EBIT Margin stood at 29082.2% in 2023, then plunged by 140 bps to 11659.43% in 2024, then jumped by 99 bps to 66.44% in 2025, then gained by 24 bps to 50.19% in 2026.
  • Per Business Quant, the three latest SEPN EBIT Margin figures stand at 50.19% (Q1 2026), 66.44% (Q4 2025), and 12.16% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Septerna 1.50 Bn 1.50 Bn - -50.19%

Historic Data

Download Data
DateValue
Mar 31, 2026 -50.19%
Dec 31, 2025 -66.44%
Sep 30, 2025 12.16%
Jun 30, 2025 -24,351.26%
Mar 31, 2025 -11,831.05%
Dec 31, 2024 -11,659.43%
Sep 30, 2024 -12,812.50%
Jun 30, 2024 -4,882.43%
Mar 31, 2024 -4,886.44%
Dec 31, 2023 29,082.20%
Sep 30, 2023 -36,484.85%